Gut Microbiota and Immunotherapy by Xiaoqing Xu, Xiaoqing Xu, Jieer Ying

Get full text

Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis by Yiwen Zhou, Jingjing Li, Jieer Ying

Get full text

Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes by Chaoqun Li, Lei Bie, Muhua Chen, Jieer Ying

Get full text

A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells by Xiaoqing Guan, Bing Zhao, Xiaodan Guan, Jinyun Dong, Jieer Ying

Get full text

Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers by Jiaojiao Ni, Yihui Huang, Chaoqun Li, Qian Yin, Jieer Ying

Get full text

An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer by Haimin Weng, Pengfei Zeng, Yuemiao Chen, Qi Xu, Jieer Ying

Get full text

XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer by Xiaoqing Guan, Yun Li, Xiaodan Guan, Linfei Fan, Jieer Ying

Get full text

The effect of anti-PD-1/PD-L1 antibodies combined with VEGF receptor tyrosine kinase inhibitors versus bevacizumab in unresectable hepatocellular carcinoma by Hui Zeng, Qi Xu, Jinyu Wang, Xiaoqing Xu, Jun Luo, Lei Zhang, Cong Luo, Jieer Ying, Jingjing Li

Get full text

Efficacy and safety of dual blockade of HER2 and PD-1 in patients with HER2-positive gastric cancer: a retrospective, multicentre study by Shuyi Cen, Meiqin Yuan, Qunan Sun, Guilan Hou, Jieer Ying, Qi Xu, Yu Zheng, Ying Dong, Hongming Pan, Weidong Han

Get full text

DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis by Qian Yin, Yinye Yao, Jiaojiao Ni, Yiwen Zhang, Jia Wu, Hui Zeng, Wei Wu, Wei Zhuo, Jieer Ying, Jingjing Li

Get full text

Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial by Jialin Tang, Sheng Hu, Suxia Luo, Zhiguo Luo, Fuxiang Zhou, Shiyun Tan, Jieer Ying, Chengyun Geng, Xiangyong Gu, Binlei Liu

Get full text

Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study by Qing Wei, Yiding Gao, Changsong Qi, Xing Yuan, Jingjing Li, Qi Xu, Cong Luo, Lei Chen, Wei Zhuo, Zhiyuan Xu, Jieer Ying

Get full text

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway by Jing Zhao, Jing Zhao, Jing Zhao, Jing Zhao, Yunfu Shi, Yunfu Shi, Yubo Ma, Yubo Ma, Yubo Ma, Yubo Ma, Libin Pan, Libin Pan, Libin Pan, Libin Pan, Yanan Wang, Yanan Wang, Yanan Wang, Yanan Wang, Li Yuan, Li Yuan, Li Yuan, Li Yuan, Jinyun Dong, Jieer Ying, Jieer Ying

Get full text

Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy by Qi Xu, Xiaoqing Xu, Haimeng Tang, Junrong Yan, Jingjing Li, Hua Bao, Xue Wu, Yang Shao, Cong Luo, Haimin Wen, Jianying Jin, Jieer Ying

Get full text

Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers by Lin Yang, Hua Bao, Xue Wu, Yong Wu, Yang Shao, Jiani C Yin, Jieer Ying, Xiangdong Cheng, Guojie Xia, Minyan Xing, Xiaoxi Chen, Jiaohui Pang, Lingjun Zhu

Get full text

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study by Ruihua Xu, Xianjun Yu, Jihui Hao, Liwei Wang, Hongming Pan, Guohong Han, Jianming Xu, Yanqiao Zhang, Shujun Yang, Jia Chen, Jieer Ying, Guanghai Dai, Mingyu Li, Damir Begic, Brian Lu, Lin Shen

Get full text

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors by Qing Wei, Peijing Li, Teng Yang, Jiayu Zhu, Lu Sun, Ziwen Zhang, Lu Wang, Xuefei Tian, Jiahui Chen, Can Hu, Junli Xue, Letao Ma, Takaya Shimura, Jianmin Fang, Jieer Ying, Peng Guo, Xiangdong Cheng

Get full text

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes by Jing Liu, Zhaoxia Wang, Yan Shi, Xue Li, Jun Zhou, Yongqian Shu, Yunpeng Liu, Jingdong Zhang, Xiaofeng Chen, Yang Shao, Fengjiao Zhao, Dongqin Zhu, Xiangcheng Li, Jieer Ying, Deqiang Wang, Jingrong Qiu, Haizhou Lou, Jiuwei Cui, Lanlan Pan, Jianyi Zhao, Shiqing Chen, Liuqing Zhu

Get full text

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response by Jingjing Li, Qing Wei, Xiaoying Wu, Jun Sima, Qi Xu, Mengmeng Wu, Fufeng Wang, Haibo Mou, Hanguang Hu, Jianguo Zhao, Da Li, Jinlin Hu, Lingnan Zhang, Xiu Zhu, Lei Chen, Cong Luo, Junrong Yan, Jiachen He, Yutong Ma, Yang Shao, Wei Wu, Jieer Ying

Get full text

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial by Dan Liu, Jun Zhou, Yongsheng Wang, Mingjun Li, Haiping Jiang, Yunpeng Liu, Xianli Yin, Minghua Ge, Xiaojun Xiang, Jieer Ying, Jian Huang, Yan-qiao Zhang, Ying Cheng, Zhigang Huang, Xianglin Yuan, Weiqing Han, Dong Yan, Xinshuai Wang, Pan Liu, Linna Wang, Xiaojing Zhang, Suxia Luo, Tianshu Liu, Lin Shen

Get full text